Today: 23 January 2026
Subscribe
Browse Category

Health News News 1 January 2026 - 20 January 2026

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares

New York, January 20, 2026, 14:21 EST — Regular session ongoing. Shares of Boston Scientific Corp climbed roughly 3.1% to $90.77 on Tuesday, clawing back some of last week’s losses. Investors digested new clinical data amid ongoing concerns over regulatory issues and deal rumors. This shift is significant since BSX is back to being a “show me” stock. Traders are…
20 January 2026
···
Eli Lilly stock set for Tuesday spotlight as new obesity-pill data ripples through GLP-1 trade

Eli Lilly stock set for Tuesday spotlight as new obesity-pill data ripples through GLP-1 trade

New York, Jan 19, 2026, 10:08 EST — Market closed Eli Lilly and Company shares drew attention heading into Tuesday’s U.S. session, following a Friday close in the green. Investors digested new developments in the obesity-drug sector, a key driver behind the drugmaker’s recent surge. The key question now: does the early appetite for new, easier-to-swallow weight-loss pills alter the…
19 January 2026
····
Why ImmunityBio stock is surging today: ANKTIVA sales jump and a key bladder-cancer trial nears the finish line

Why ImmunityBio stock is surging today: ANKTIVA sales jump and a key bladder-cancer trial nears the finish line

New York, Jan 16, 2026, 10:16 EST — Regular session ImmunityBio shares surged roughly 16.5% to $4.60 Friday morning, building on a strong rally after the biotech reported better-than-expected sales momentum for its main cancer drug. The company also detailed plans for a label-expansion effort. Trading volume exceeded 56 million shares, with the stock reaching an intraday peak of $5.20.…
16 January 2026
·····
Costco Canada recall expands: Peace by Chocolate pistachio chocolates pulled over salmonella risk

Costco Canada recall expands: Peace by Chocolate pistachio chocolates pulled over salmonella risk

Ottawa, January 9, 2026, 14:59 EST Costco Wholesale Canada told customers who bought certain Peace by Chocolate gift boxes online to stop eating two pistachio-containing chocolates, after an ingredient supplier triggered a warning over possible Salmonella contamination. The “voluntary, precautionary” recall covers Our Classic Box – 15 assorted filled chocolates (lot codes — the batch numbers on the packaging —…
9 January 2026
Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

New York, Jan 7, 2026, 18:52 EST — After-hours Merck & Co (MRK.N) shares edged down in after-hours trading on Wednesday after U.S. health officials updated the childhood immunization schedule and moved to a single dose for the human papillomavirus (HPV) vaccine, a change that could pressure demand for Merck’s Gardasil shot. The stock was down about 0.2% at $108.60,…
8 January 2026
···
Novo Nordisk (NVO) stock jumps as $149 Wegovy pill rollout puts pricing in the spotlight

Novo Nordisk (NVO) stock jumps as $149 Wegovy pill rollout puts pricing in the spotlight

New York, Jan 6, 2026, 10:40 EST — Regular session Novo Nordisk A/S shares listed in New York as ADRs climbed about 4.7% to $57.71 on Tuesday, after touching an intraday high of $58.14. The move extends a rebound sparked by the U.S. rollout of a pill version of Wegovy, a franchise that has become central to how investors value…
6 January 2026
····
Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

New York, January 6, 2026, 07:27 EST — Premarket Novo Nordisk’s U.S.-listed shares rose about 4% in premarket trading on Tuesday, extending gains after the Danish drugmaker began selling its once-daily Wegovy weight-loss pill in the United States. The stock was up at $57.29, compared with a prior close of $55.11. Public The launch lands as investors debate how fast…
6 January 2026
····
Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

New York, January 5, 2026, 21:32 (EST) — Market closed Merck & Co shares dipped in late trading on Monday after U.S. health officials rewrote the childhood and adolescent immunization schedule, including a change to a one-dose recommendation for the human papillomavirus (HPV) vaccine. Merck (MRK.N) closed up 0.93% at $107.44 and was last down 0.22% at $107.20 after the…
6 January 2026
··
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

New York, January 5, 2026, 14:21 EST — Regular session Shares of Viking Therapeutics (VKTX) slid 9.9% to $31.93 in afternoon trading on Monday as obesity-drug stocks reacted to Novo Nordisk’s U.S. launch of a Wegovy weight-loss pill. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly fell 3.9% and the SPDR S&P Biotech ETF dropped 2.2%. The move highlights how…
5 January 2026
···
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

New York, Jan 5, 2026, 13:31 EST — Regular session Arrowhead Pharmaceuticals shares were down about 6.9% on Monday after the company said Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock fell $4.68 to $63.11 after swinging between $60.75 and $70.87. MarketScreener The clearance gives Arrowhead another regulated market for its first commercial product, as…
5 January 2026
····
Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

LONDON, January 4, 2026, 13:02 ET Britain’s Tesco has recalled three 170-gram own-brand pate products after they were labelled with an incorrect use-by date, prompting a warning over a possible microbiological risk, the UK’s Food Standards Agency said on Jan. 3. The recall covers Tesco Coarse Farmhouse Pate, Coarse Ardennes Pate and Smooth Chicken Liver Pate with a use-by date…
4 January 2026
Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

NEW YORK, January 1, 2026, 06:51 ET Bupa UK on Wednesday renewed its role as Official Healthcare Partner of ParalympicsGB and agreed a new three-year contract between Bupa UK Insurance and Nuffield Health, the company said. The Nuffield agreement adds direct appointment booking and wider access to diagnostics for Bupa customers. (Source) The moves matter because speed to diagnosis is…
1 January 2026
··
1 2 3 4

Stock Market Today

  • Davide Campari-Milano Stock Forecast 2026-2030: Analyst Price Targets and Market Outlook
    January 23, 2026, 10:28 AM EST. Davide Campari-Milano (CPR) trades near €5.80 as of 16 January 2026, with steady intraday fluctuations amid ongoing portfolio streamlining and balance-sheet initiatives. Analysts forecast a moderate upside within 12 months, with average price targets ranging from €6.86 to €7.05 across MarketScreener, Fintel, and TradingView. The forecasts reflect expected valuation adjustments based on the company's focus on core brands and geographic expansion, while broader European market trends and earnings updates also influence estimates. Price targets span a wide range, from lows around €4.20 to highs up to €11.55, indicating diverse views on the stock's potential.
Go toTop